Antiretroviral therapy coverage in Argentina
Argentina: Antiretroviral therapy coverage was 79.0% in 2024. ▲ Rising
Antiretroviral therapy coverage in Argentina, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Argentina recorded 79.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 2.6% on the previous year and up 36.2% over ten years.
Over the whole period, antiretroviral therapy coverage in Argentina peaked at 79.0% in 2024 and was at its lowest, 18.0%, in 2000.
That places Argentina 53rd out of 143 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Antiretroviral therapy coverage in Argentina, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 18.0% | — |
| 2001 | 22.0% | +22.2% |
| 2002 | 25.0% | +13.6% |
| 2003 | 28.0% | +12.0% |
| 2004 | 31.0% | +10.7% |
| 2005 | 33.0% | +6.5% |
| 2006 | 35.0% | +6.1% |
| 2007 | 38.0% | +8.6% |
| 2008 | 41.0% | +7.9% |
| 2009 | 43.0% | +4.9% |
| 2010 | 46.0% | +7.0% |
| 2011 | 49.0% | +6.5% |
| 2012 | 52.0% | +6.1% |
| 2013 | 55.0% | +5.8% |
| 2014 | 58.0% | +5.5% |
| 2015 | 61.0% | +5.2% |
| 2016 | 64.0% | +4.9% |
| 2017 | 66.0% | +3.1% |
| 2018 | 68.0% | +3.0% |
| 2019 | 70.0% | +2.9% |
| 2020 | 72.0% | +2.9% |
| 2021 | 74.0% | +2.8% |
| 2022 | 76.0% | +2.7% |
| 2023 | 77.0% | +1.3% |
| 2024 | 79.0% | +2.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 31.4% | 18.0% | 43.0% | 10 |
| 2010s | 58.9% | 46.0% | 70.0% | 10 |
| 2020s | 75.6% | 72.0% | 79.0% | 5 |
Countries ranked near Argentina
- 51 Cape Verde 80.0% compare
- 51 Peru 80.0% compare
- 53 Guinea-Bissau 79.0% compare
- 53 Lebanon 79.0% compare
- 53 Senegal 79.0% compare
More health data for Argentina
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6333 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,462 deaths per 1,000 people (2090)
- Number of infants who die before age 1 684 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.7 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0269 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.7 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Argentina?
- Antiretroviral therapy coverage in Argentina was 79.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Argentina?
- The highest recorded value was 79.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Argentina?
- The lowest recorded value was 18.0% in 2000.
- How does Argentina rank for antiretroviral therapy coverage?
- Argentina ranks 53rd out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Argentina?
- Over the last ten years it is up 36.2%. The long-run trend across the full record is rising.
- Where does this Argentina data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.